2021 ASM / R-0283
The role of SUV measured on 18F-FDG PET/CT in follicular lymphoma versus diffuse large B-cell lymphoma: a retrospective review
Keywords:
Nuclear medicine, PET-CT, Molecular imaging, Lymphoma
Authors:
T. Skalina, J. Blazak; Sunshine Coast, QLD/AU
DOI:
10.26044/ranzcr2021/R-0283
References
- Alobthani G, Romanov V, Isohashi K, et al. Value of (18)F-FDG PET/CT in discrimination between indolent and aggressive non-Hodgkin's lymphoma: A study of 328 patients. Hellenic journal of nuclear medicine. 2018;21(1):7-14. doi:10.1967/s002449910701.
- Gallamini A, Borra A. FDG-PET Scan: a new Paradigm for Follicular Lymphoma Management. Mediterr J Hematol Infect Dis. 2017;9(1):e2017029-e. doi:10.4084/MJHID.2017.029.
- Jerusalem G, Beguin Y, Najjar F, et al. Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL). Annals of oncology : official journal of the European Society for Medical Oncology. 2001;12(6):825-30. doi:10.1023/a:1011169332265.
- Li H, Wang X, Zhang L, Yi X, Qiao Y, Jin Q. Correlations between maximum standardized uptake value measured via 18 F-fluorodeoxyglucose positron emission tomography/computed tomography and clinical variables and biochemical indicators in adult lymphoma. J Cancer Res Ther. 2019;15:1581. doi:10.4103/jcrt.JCRT_671_18.
- Schöder H, Noy A, Gönen M, et al. Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma. J Clin Oncol. 2005;23(21):4643-51. doi:10.1200/jco.2005.12.072.
- Mir F, Barrington SF, Brown H, et al. Baseline SUVmax did not predict histological transformation in follicular lymphoma in the phase 3 GALLIUM study. Blood. 2020 Apr 9;135(15):1214-1218. doi: 10.1182/blood.2019001091.
Acknowledgements
We would like to acknowledge the work of Dr Joanne Perry-Keene (RCPA Anatomical Pathologist) and Dr Sebastian Senff (Anatomical Pathology registrar) for their contribution to the anatomical pathology slides.